ARROWHEAD PHARMACEUTICALS IN (ARWR)
US04280A1007 - Common Stock
Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma
Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Results
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
First Week of December 20th Options Trading For Arrowhead Pharmaceuticals (ARWR)
Turnstone Biologics Appoints William Waddill to its Board of Directors
Arrowhead Pharmaceuticals is Now Oversold (ARWR)
The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Get An Even Better Deal On ARWR Than Director Lu Did
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
Friday 3/22 Insider Buying Report: DCTH, ARWR
Noteworthy Thursday Option Activity: ARWR, RBLX, MRNA
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Investors Land ARWR Even Cheaper Than Its Secondary Stock Offering
The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024
The Russell 2000 is up about 4% year to date, and could push higher, taking the most undervalued Russell 2000 stocks along for the ride.
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
Arrowhead Pharmaceuticals jumps amid takeover speculation (NASDAQ:ARWR)
Arrowhead Pharmaceuticals stock surges 11% as takeover rumors swirl, with speculation of a rejected $45 per share offer from a US-based pharmaceutical...
7 Oversold Russell 2000 Stocks to Add to Your February Buy List
Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong.
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
First Week of ARWR April 19th Options Trading
7 Biotech Stocks Fighting America’s Deadliest Diseases
Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.
Arrowhead stock slides 6% as fiscal Q1 report falls short of estimates (NASDAQ:ARWR)
Arrowhead Pharmaceuticals (ARWR) stock fell 6% in post-market trading Tuesday after the biotech company’s fiscal Q1 earnings report fell short of Street estimates. Read more here.
Arrowhead Pharmaceuticals GAAP EPS of -$1.24 misses by $0.43, revenue of $3.55M misses by $26.09M (NASDAQ:ARWR)
Arrowhead Pharmaceuticals reports disappointing first-quarter results, with EPS missing by $0.43 and revenue missing by $26.09M, causing shares to decline...
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
Notable earnings after Tuesday's close
Major earnings expected after the bell on Tuesday include:Ford Motor Company (F)Gilead Sciences (GILD)Amgen (AMGN)Enphase Energy (ENPH) Snap (SNAP)Other...
Notable Two Hundred Day Moving Average Cross - ARWR
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 First Quarter Results